Skip to main content


Browse news, expert commentary, and educational content on lupus.


Close up of medical disposable syringe and vial

14-11-2022 | ACR 2022 | Conference coverage | News

Phase 3 trial supports add-on telitacicept for SLE

Addition of the recombinant fusion protein telitacicept to standard care may reduce disease activity and is well tolerated in people with systemic lupus erythematosus, research suggests.

Close up young woman taking pill, holding water glass

01-11-2022 | Systemic lupus erythematosus | News

Dapagliflozin may warrant further investigation for SLE

Dapagliflozin deserves further study as an add-on therapy for reducing renal and cardiovascular risk in patients with systemic lupus erythematosus, suggest preliminary trial findings.

Clogged Artery, Arteriosclerosis Cholesterol plaque. 3d illustration

01-09-2022 | Cardiovascular disease | News

CV risk reduction should be ‘an integral part’ of autoimmune disease management

A large study published in The Lancet has found that people with autoimmune diseases have an approximately 1.4–3.6-fold increased risk for developing cardiovascular disease relative to the general population.

Keep up with podcasts on this topic, available on